Eureka (ASX:EGH) share price climbs higher on AGM update

The Eureka Group Holdings Ltd (ASX: EGH) share price has climbed higher today following the release of its AGM.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Eureka Group Holdings Ltd (ASX: EGH) share price has climbed higher today following the release of its AGM.

During early afternoon trade, shares in the property asset company are up 1.3% to 38.5 cents.

Let's take a closer look at what was said in its annual address to shareholders.

group of seniors happily clapping representing rising eureka share price

Image source: Getty Images

Key highlights

During FY20, Eureka completed a number of significant milestones while progressing through its transformation process. This included the acquisition of Liberty Vilas, a 124-unit village in Bundaberg, Queensland, and the disposal of its Terranora units.

Year-end occupancy rates grew to 95% compared to 91% in 2019, and solar energy enhancements were made in 13 villages.

The company reported a net profit after tax of $8.1 million compared to the $6.7 million achieved in 2019.

Underlying earnings before interest tax and depreciation (EBITDA) came to $8.7 million, up 11% on the prior corresponding period.

Net operating cash flow stood at $7.6 million, up 60% although this included a one-off GST refund of $0.6 million.

Net debt jumped to $52 million, however the group's gearing remained at an acceptable level, with a margin of 37.7%. To allow room for further acquisitions, Eureka expanded its debt facility from $60 million to $77.5 million.

The board pleasingly introduced a dividend reinvestment plan that will commence in 2021.

Outlook for FY21

Due to the continued momentum during the first four months of the 2021 financial year, Eureka updated its FY21 outlook.

Operating results have been encouraging with EBITDA, and net profit after tax is ahead of budget and the prior year. Eureka expects to maintain trading to be consistent with current results.

Forecasted underlying EBITDA for FY21 is estimated to be in the range of $9.8 million and $10.2 million. This excludes asset revaluations, sales at Terranora and any unforeseen expenses.

Implementation of an integrated technology system is a key priority for Eureka as it looks to provide real time reporting and analysis.

In addition, the company will focus on growth in the area of offering accommodation to independent seniors. Eureka noted that not only would this improve cash flows, but also operate its assets on a low risk social infrastructure framework.

Eureka share price summary

The Eureka share price has made a strong turnaround from reaching its 52-week low of 26 cents. Trading at relatively the same levels as the beginning of the year, the company is a whisker away from reaching a multi-year high of 40.5 cents.

Eureka has a current market capitalisation of $89.7 million and a price-to-earning (P/E) ratio of 11.4.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »